PMID- 17896346
OWN - NLM
STAT- MEDLINE
DCOM- 20080117
LR  - 20131121
IS  - 0885-6222 (Print)
IS  - 0885-6222 (Linking)
VI  - 22
IP  - 7
DP  - 2007 Oct
TI  - The neuropsychology of ecstasy (MDMA) use: a quantitative review.
PG  - 427-35
AB  - A growing number of empirical studies have found varying neuropsychological 
      impairments associated with use of 3,4-methylenedioxymethamphetamine (MDMA) use. 
      We set out to determine to what extent neuropsychological abilities are impaired 
      in MDMA users. To do so, meta-analytical methods were used to determine the 
      magnitude of neuropsychological impairment in MDMA users across pre-specified 
      cognitive domains. We found that cognitive impairment secondary to recreational 
      drug use may result in what might be described as small-to-medium effects across 
      all cognitive domains with learning and memory being most impaired. We also found 
      that total lifetime ingestion of MDMA appears to be negatively associated with 
      performance on tasks ranging from attention and concentration to learning and 
      memory. Implications and limitations of these findings are discussed.
CI  - Copyright 2007 John Wiley & Sons, Ltd.
FAU - Zakzanis, Konstantine K
AU  - Zakzanis KK
AD  - Department of Psychology, University of Toronto at Scarborough, Toronto, Ontario, 
      Canada. zakzanis@utsc.utoronto.ca
FAU - Campbell, Zachariah
AU  - Campbell Z
FAU - Jovanovski, Diana
AU  - Jovanovski D
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PL  - England
TA  - Hum Psychopharmacol
JT  - Human psychopharmacology
JID - 8702539
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Attention/drug effects
MH  - Cognition Disorders/*chemically induced
MH  - Hallucinogens/*adverse effects
MH  - Humans
MH  - Learning/drug effects
MH  - Memory/drug effects
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects
MH  - Neuropsychological Tests
MH  - Psychomotor Performance/drug effects
RF  - 71
EDAT- 2007/09/27 09:00
MHDA- 2008/01/18 09:00
CRDT- 2007/09/27 09:00
PHST- 2007/09/27 09:00 [pubmed]
PHST- 2008/01/18 09:00 [medline]
PHST- 2007/09/27 09:00 [entrez]
AID - 10.1002/hup.873 [doi]
PST - ppublish
SO  - Hum Psychopharmacol. 2007 Oct;22(7):427-35. doi: 10.1002/hup.873.